BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37293158)

  • 1. Incidence and risk factors for venous thromboembolism in patients with ovarian cancer during neoadjuvant chemotherapy: a meta-analysis.
    Han L; Chen Y; Zheng A; Chen H
    Am J Cancer Res; 2023; 13(5):2126-2134. PubMed ID: 37293158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature review.
    Moufarrij S; Sassine D; Basaran D; Jewell EL
    Gynecol Oncol; 2023 Mar; 170():167-171. PubMed ID: 36701837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.
    Basaran D; Boerner T; Suhner J; Sassine D; Liu Y; Grisham RN; Tew WP; Gardner GJ; Zivanovic O; Sonoda Y; Long Roche K; Chi DS; Abu-Rustum NR; Soff GA; Jewell EL
    Gynecol Oncol; 2021 Oct; 163(1):36-40. PubMed ID: 34312001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian Cancer and Impact on Survival.
    Black KA; Ghosh S; Singh N; Chu P; Pin S
    J Obstet Gynaecol Can; 2021 Dec; 43(12):1380-1387. PubMed ID: 34087490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis.
    Di Nisio M; Candeloro M; Rutjes AWS; Porreca E
    J Thromb Haemost; 2018 Jul; 16(7):1336-1346. PubMed ID: 29754426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis.
    Ye L; Cai L; Fu Y; Zhuang D; Hu X; Jie Y
    World J Surg Oncol; 2021 Jan; 19(1):12. PubMed ID: 33441137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.
    Chokshi SK; Gaughan JP; Krill L
    J Thromb Thrombolysis; 2022 Jan; 53(1):202-207. PubMed ID: 34185227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis.
    Black KA; Bowden S; Chu P; McClurg C; Pin S; Metcalfe A
    Int J Gynecol Cancer; 2024 Jun; 34(6):855-862. PubMed ID: 38431288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.
    Chavan DM; Huang Z; Song K; Parimi LRH; Yang XS; Zhang X; Liu P; Jiang J; Zhang Y; Kong B; Li L
    Medicine (Baltimore); 2017 Oct; 96(42):e7935. PubMed ID: 29049188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and risk of venous thromboembolism associated with peripherally inserted central venous catheters in hospitalized patients: A systematic review and meta-analysis.
    Puri A; Dai H; Giri M; Wu C; Huang H; Zhao Q
    Front Cardiovasc Med; 2022; 9():917572. PubMed ID: 35958406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
    Morrison J; Haldar K; Kehoe S; Lawrie TA
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD005343. PubMed ID: 22895947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.
    Coleridge SL; Bryant A; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD005343. PubMed ID: 34328210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Noumegni SR; Hoffmann C; Tromeur C; Lacut K; Didier R; Couturaud F; Bressollette L
    Thromb Res; 2021 Jul; 203():172-185. PubMed ID: 34029849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis.
    Ungprasert P; Koster MJ; Thongprayoon C; Warrington KJ
    Clin Rheumatol; 2016 Nov; 35(11):2741-2747. PubMed ID: 27572522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis.
    Bajaj NS; Vaduganathan M; Qamar A; Gupta K; Gupta A; Golwala H; Butler J; Goldhaber SZ; Mehra MR
    PLoS Med; 2019 Apr; 16(4):e1002797. PubMed ID: 31034476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.